Utah Medical Products annual gross margin
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Utah Medical Products Gross Margin Growth & History (UTMD)
Utah Medical Products's gross margin was 57.12% for fiscal 2025.
View full Utah Medical Products company overviewUtah Medical Products annual gross margin history
| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 57.12% | −1.91 pp |
| 2024 | 2024-12-31 | 59.03% | −0.78 pp |
| 2023 | 2023-12-31 | 59.81% | −1.77 pp |
| 2022 | 2022-12-31 | 61.58% | −1.44 pp |
| 2021 | 2021-12-31 | 63.03% | +2.45 pp |
| 2020 | 2020-12-31 | 60.57% | −2.25 pp |
| 2019 | 2019-12-31 | 62.82% | +0.19 pp |
| 2018 | 2018-12-31 | 62.64% | −1.10 pp |
| 2017 | 2017-12-31 | 63.73% | +3.45 pp |
| 2016 | 2016-12-31 | 60.28% | +0.06 pp |
| 2015 | 2015-12-31 | 60.23% | −0.30 pp |
| 2014 | 2014-12-31 | 60.52% | +0.58 pp |
| 2013 | 2013-12-31 | 59.94% | −0.96 pp |
| 2012 | 2012-12-31 | 60.90% | +1.74 pp |
| 2011 | 2011-12-31 | 59.17% | +6.58 pp |
| 2010 | 2010-12-31 | 52.58% | −0.63 pp |
| 2009 | 2009-12-31 | 53.21% | — |
Utah Medical Products quarterly gross margin
Q2.10
Q3.10
Q1.11
Q2.11
Q3.11
Q4.11
Q1.12
Q2.12
Q3.12
Q4.12
Q1.13
Q2.13
Q3.13
Q4.13
Q1.14
Q2.14
Q3.14
Q4.14
Q1.15
Q2.15
Q3.15
Q4.15
Q1.16
Q2.16
Q3.16
Q4.16
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | 55.79% | −0.43 pp |
| Q1 2026 | 2026-03-31 | 60.56% | +3.53 pp |
| Q4 2025 | 2025-12-31 | 58.20% | +0.07 pp |
| Q3 2025 | 2025-09-30 | 57.11% | −0.88 pp |
| Q2 2025 | 2025-06-30 | 56.21% | −3.91 pp |
| Q1 2025 | 2025-03-31 | 57.03% | −2.63 pp |
| Q4 2024 | 2024-12-31 | 58.13% | +0.58 pp |
| Q3 2024 | 2024-09-30 | 57.99% | −0.86 pp |
| Q2 2024 | 2024-06-30 | 60.12% | −0.03 pp |
| Q1 2024 | 2024-03-31 | 59.66% | −2.98 pp |
| Q4 2023 | 2023-12-31 | 57.55% | −3.79 pp |
| Q3 2023 | 2023-09-30 | 58.85% | −4.34 pp |
| Q2 2023 | 2023-06-30 | 60.15% | −0.55 pp |
| Q1 2023 | 2023-03-31 | 62.64% | +1.51 pp |
| Q4 2022 | 2022-12-31 | 61.34% | −1.47 pp |
| Q3 2022 | 2022-09-30 | 63.19% | −1.03 pp |
| Q2 2022 | 2022-06-30 | 60.70% | −1.06 pp |
| Q1 2022 | 2022-03-31 | 61.13% | −2.23 pp |
| Q4 2021 | 2021-12-31 | 62.82% | +2.32 pp |
| Q3 2021 | 2021-09-30 | 64.21% | +2.21 pp |
| Q2 2021 | 2021-06-30 | 61.77% | +5.43 pp |
| Q1 2021 | 2021-03-31 | 63.36% | +0.66 pp |
| Q4 2020 | 2020-12-31 | 60.49% | −5.56 pp |
| Q3 2020 | 2020-09-30 | 62.00% | +2.94 pp |
| Q2 2020 | 2020-06-30 | 56.33% | −6.98 pp |
| Q1 2020 | 2020-03-31 | 62.70% | −0.41 pp |
| Q4 2019 | 2019-12-31 | 66.05% | +3.46 pp |
| Q3 2019 | 2019-09-30 | 59.06% | −1.52 pp |
| Q2 2019 | 2019-06-30 | 63.31% | −0.38 pp |
| Q1 2019 | 2019-03-31 | 63.11% | −0.47 pp |
| Q4 2018 | 2018-12-31 | 62.59% | −0.84 pp |
| Q3 2018 | 2018-09-30 | 60.58% | −3.58 pp |
| Q2 2018 | 2018-06-30 | 63.69% | +0.04 pp |
| Q1 2018 | 2018-03-31 | 63.58% | −0.12 pp |
| Q4 2017 | 2017-12-31 | 63.43% | +1.97 pp |
| Q3 2017 | 2017-09-30 | 64.16% | +4.34 pp |
| Q2 2017 | 2017-06-30 | 63.65% | +4.05 pp |
| Q1 2017 | 2017-03-31 | 63.70% | +3.29 pp |
| Q4 2016 | 2016-12-31 | 61.46% | −0.07 pp |
| Q3 2016 | 2016-09-30 | 59.81% | −1.31 pp |
| Q2 2016 | 2016-06-30 | 59.60% | +0.94 pp |
| Q1 2016 | 2016-03-31 | 60.41% | +0.68 pp |
| Q4 2015 | 2015-12-31 | 61.52% | −0.84 pp |
| Q3 2015 | 2015-09-30 | 61.13% | +3.31 pp |
| Q2 2015 | 2015-06-30 | 58.66% | −1.86 pp |
| Q1 2015 | 2015-03-31 | 59.73% | −1.84 pp |
| Q4 2014 | 2014-12-31 | 62.36% | +2.92 pp |
| Q3 2014 | 2014-09-30 | 57.81% | −1.49 pp |
| Q2 2014 | 2014-06-30 | 60.52% | +0.05 pp |
| Q1 2014 | 2014-03-31 | 61.57% | +1.02 pp |
| Q4 2013 | 2013-12-31 | 59.44% | −1.79 pp |
| Q3 2013 | 2013-09-30 | 59.30% | −2.45 pp |
| Q2 2013 | 2013-06-30 | 60.47% | −0.09 pp |
| Q1 2013 | 2013-03-31 | 60.55% | +0.42 pp |
| Q4 2012 | 2012-12-31 | 61.24% | +1.56 pp |
| Q3 2012 | 2012-09-30 | 61.75% | +1.31 pp |
| Q2 2012 | 2012-06-30 | 60.56% | +0.23 pp |
| Q1 2012 | 2012-03-31 | 60.13% | +5.51 pp |
| Q4 2011 | 2011-12-31 | 59.68% | — |
| Q3 2011 | 2011-09-30 | 60.44% | +6.64 pp |
| Q2 2011 | 2011-06-30 | 60.33% | +8.27 pp |
| Q1 2011 | 2011-03-31 | 54.62% | — |
| Q3 2010 | 2010-09-30 | 53.80% | — |
| Q2 2010 | 2010-06-30 | 52.06% | — |
Utah Medical Products gross margin trends
Over the last five fiscal years, Utah Medical Products's gross margin decreased from 60.57% to 57.12%, a change of −3.46 percentage points. The latest reported quarter, Q2 2026, shows 55.79%.
About the metric
What gross margin means
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
Calculation and source
How gross margin is calculated
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Utah Medical Products source filings ↗Community posts
Utah Medical launches $75-per-share self-tender offer
Utah Medical Products ($UTMD) commenced a tender offer to repurchase up to 650,000 common shares at $75 each. At full acceptance, the share purchase would total $48.75 million before related costs. The offer follows previously announced ter ...
